Eiger BioPharmaceuticals, Inc. (EIGR)
NASDAQ: EIGR · IEX Real-Time Price · USD
5.01
+0.04 (0.70%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Eiger BioPharmaceuticals Market Cap
Eiger BioPharmaceuticals has a market cap or net worth of $7.40 million as of March 28, 2024. Its market cap has decreased by -84.04% in one year.
Market Cap
7.40M
Enterprise Value
8.92M
1-Year Change
-84.04%
Ranking
Category
Stock Price
$5.01
Market Cap Chart
Since January 30, 2014, Eiger BioPharmaceuticals's market cap has decreased from $140.60M to $7.40M, a decrease of -94.73%. That is a compound annual growth rate of -25.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 7.40M | -6.33% |
Mar 26, 2024 | 7.90M | -4.82% |
Mar 25, 2024 | 8.30M | -2.35% |
Mar 22, 2024 | 8.50M | -3.41% |
Mar 21, 2024 | 8.80M | 11.39% |
Mar 20, 2024 | 7.90M | 11.27% |
Mar 19, 2024 | 7.10M | -6.58% |
Mar 18, 2024 | 7.60M | - |
Mar 15, 2024 | 7.60M | -3.80% |
Mar 14, 2024 | 7.90M | -11.24% |
Mar 13, 2024 | 8.90M | 2.30% |
Mar 12, 2024 | 8.70M | -13.00% |
Mar 11, 2024 | 10.00M | -1.96% |
Mar 8, 2024 | 10.20M | -3.77% |
Mar 7, 2024 | 10.60M | 4.95% |
Mar 6, 2024 | 10.10M | -1.94% |
Mar 5, 2024 | 10.30M | 11.96% |
Mar 4, 2024 | 9.20M | -11.54% |
Mar 1, 2024 | 10.40M | 25.30% |
Feb 29, 2024 | 8.30M | -3.49% |
Feb 28, 2024 | 8.60M | - |
Feb 27, 2024 | 8.60M | - |
Feb 26, 2024 | 8.60M | 7.50% |
Feb 23, 2024 | 8.00M | -6.98% |
Feb 22, 2024 | 8.60M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Theriva Biologics | 8.18M |
GlucoTrack | 8.18M |
Applied DNA Sciences | 8.15M |
Trevena | 8.12M |
NeuroMetrix | 7.95M |
Heart Test Laboratories | 7.87M |
First Wave BioPharma | 7.84M |
Protagenic Therapeutics | 7.76M |